Gambro Signs Loan of Euro 150 Million with the European Investment Bank
June 06, 2002 04:05 ET
|
Gambro
STOCKHOLM, Sweden, June 6, 2002 (PRIMEZONE) -- Gambro AB (Stockholmsborsen:GAMBaST) (Stockholmsborsen:GAMBbST), a leading international medical technology and healthcare company, today announced that...
Tripep Invests in Drug Against Development and Spread of Multiresistant Bacteria
June 06, 2002 01:08 ET
|
Tripep
HUDDINGE, Sweden, June 6, 2002 (PRIMEZONE) -- Tripep AB (publ) will subscribe for new shares corresponding to 30% of the share capital in Finnish biotech-company Ipsat Therapies Oy, with an option to...
Medical Solutions Plc: Guys and St. Thomas' Hospitals use Spirigel
June 05, 2002 05:33 ET
|
Medical Solutions
LEEDS, U.K., June 5, 2002 (PRIMEZONE) -- Medical Solutions (LSE:MLS), the specialist healthcare company, announces that its subsidiary Adams Healthcare has added Guys and St. Thomas NHS Trust to the...
Wilson Greatbatch Technologies, Inc. Announces Completion of Major Research and Development Facilities Expansion at its Western New York Location
June 04, 2002 11:00 ET
|
Wilson Greatbatch Technologies, Inc.
CLARENCE, N.Y., June 4, 2002 (PRIMEZONE) -- Wilson Greatbatch Technologies, Inc. ("WGT") (NYSE:GB), a leading developer and manufacturer of power sources and other critical components used in...
Cardio Control Earns Record Sale; Expects Further Growth
June 03, 2002 08:37 ET
|
Cardio Control NV
DELFT, The Netherlands, June 3, 2002 (PRIMEZONE) -- Cardio Control NV (AMS:CADI), specializing in Medical Diagnostic Software Solutions, received its biggest order within its 20-year history and also...
Pharmexa Receives Top Ranking in Danish Corporate Governance Award
May 29, 2002 07:35 ET
|
Pharmexa A/S
HOERSHOLM, Denmark, May 29, 2002 (PRIMEZONE) -- The Danish Shareholders Association has announced the results of the Danish Corporate Governance Award 2002. The Award is based on 17 criteria around...
Medivir: Proof of Principle in Research on Treatment of Multiple Sclerosis
May 29, 2002 04:14 ET
|
Medivir
HUDDINGE, Sweden, May 29, 2002 (PRIMEZONE) -- Medivir and Peptimmune jointly announced today that, an orally active, small molecule inhibitor of the protease enzyme Cathepsin S, suppresses the...
Vitrolife Opens U.S. Subsidiary for Its Cross-Linked Hyaluronan Dermal Implant Business
May 24, 2002 05:05 ET
|
Vitrolife
STOCKHOLM, Sweden, May 24, 2002 (PRIMEZONE) -- Vitrolife has opened a U.S. subsidiary, A-Life, Inc. in Newport Beach, California, to focus on final clinical development and marketing of its double...
AorTech International plc: Restructuring and Rationalization of Facilities
May 24, 2002 04:48 ET
|
AorTech International Plc
LANARKSHIRE, Scotland, May 24, 2002 (PRIMEZONE) -- AorTech International plc ("AorTech") (LSE:AOR), the Scottish-based developer and manufacturer of cardiovascular devices, announces a restructuring...
Pharmexa A/S: Interim Report for the First 3 Months of the Financial Year 2002
May 23, 2002 06:54 ET
|
Pharmexa A/S
HOERSHOLM, Denmark, May 23, 2002 (PRIMEZONE) -- The Pharmexa Group had turnover of kDKK 4,893 in the first 3 months of 2002 and realised a net loss of kDKK 33,939. Research and Development costs...